Cimerli

Indicated For

age-related macular degeneration, diabetic macular edema, diabetic retinopathy, macular edema following retinal vein occlusion, myopic choroidal neovascularization

About This Medication

# Sandoz One Source Patient Assistance Program: How to Get Cimerli (Ranibizumab-eqrn) at Low or No Cost ## About This Program The **Sandoz One Source Patient Assistance Program** is designed to help eligible patients access Cimerli (ranibizumab-eqrn) and other Sandoz medications at reduced or no cost. Sandoz, a division of Novartis, is committed to ensuring that financial barriers do not prevent patients from receiving the medications they need. ## About Cimerli (Ranibizumab-eqrn) Cimerli is a biosimilar version of Lucentis (ranibizumab), a medication used to treat certain eye conditions including age-related macular degeneration (AMD), diabetic macular edema (DME), and retinal vein occlusion (RVO). As a biosimilar, Cimerli is highly similar to the original biologic drug and works in the same way to help preserve vision and slow disease progression. ## Who Qualifies for This Program? You may be eligible for the Sandoz One Source program if you meet the following criteria: - You have a valid prescription for Cimerli from a licensed healthcare provider - You are a U.S. resident - Your healthcare provider has determined that Cimerli is medically necessary for your condition - You meet the insurance requirements outlined below ### Insurance Requirements The program serves patients with different types of insurance coverage: | Insurance Type | Eligibility | |---|---| | Commercial Insurance | Eligible for co-pay assistance programs | | Medicare | Eligible for patient assistance | | Medicaid | Eligible for patient assistance | | Uninsured | May qualify for full medication assistance | **Important:** Patients cannot simultaneously participate in state or federally funded programs (such as Veterans Administration, Department of Defense, or TRICARE) while enrolled in the commercial co-pay program. ## Income Eligibility While specific income thresholds for the Sandoz One Source program have not been publicly disclosed, the program is designed to assist patients most in need. During the application process, you will be asked to provide financial information to determine your eligibility. It is recommended that you contact the program directly to discuss your specific financial situation. ## How to Apply: Step-by-Step ### Step 1: Gather Required Documents Before starting your application, have the following information ready: - Your valid prescription for Cimerli from your healthcare provider - Proof of U.S. residency - Insurance information (insurance card or policy details) - Financial documentation if applying for full medication assistance - Your healthcare provider's contact information ### Step 2: Choose Your Application Method You have multiple ways to apply: **Online Application:** - Visit the Sandoz One Source website or your healthcare provider's patient portal - Complete the enrollment form for your patient type (adult or pediatric) - Submit required documents electronically - Receive immediate card approval if eligible **Phone Application:** - Call **1-844-726-3691** to speak with a Sandoz One Source Case Manager - A representative can answer questions and guide you through the process - Hours: Monday through Friday, 8 AM–8 PM ET **Fax Application:** - Download the Sandoz One Source enrollment form - Complete all required sections - Have your healthcare provider sign the form - Fax to **1-844-726-3695** ### Step 3: Healthcare Provider Involvement Your doctor or healthcare provider must: - Complete their section of the application form - Sign and date the form (electronic signature accepted) - Provide a brand-name prescription for Cimerli - Confirm that the medication is medically necessary Your healthcare provider can also enroll you directly in the program on your behalf. ### Step 4: Submit Your Application Submit your completed application through your chosen method. Ensure all required fields are completed and all necessary documents are attached. ## Timeline and Delivery **Approval Timeline:** If you apply online and are eligible, your co-pay assistance card may be available immediately upon approval. For applications submitted by phone or fax, processing times may vary. Contact Sandoz One Source directly for specific timeline information regarding your application. **Medication Delivery:** Once approved, your medication will be shipped according to your prescription and healthcare provider's instructions. Delivery methods and timeframes will be communicated during the enrollment process. ## Co-Pay Assistance Benefits If you have commercial insurance, you may qualify for co-pay assistance with benefits including: - Co-pays as low as **$0** for eligible patients - Annual benefit cap of up to **$10,000** - No expiration date on your assistance card - Automatic annual reset of benefits - Immediate card availability upon approval ## Additional Support Services Beyond medication assistance, Sandoz One Source offers: - **Benefits Investigation:** Help understanding your insurance coverage - **Prior Authorization Support:** Assistance navigating insurance approval processes - **Nurse Ambassadors:** Support with injection training and insurance navigation - **Field Reimbursement Managers:** Answers to reimbursement and coverage questions - **Product Replacement Program:** Replacement of damaged or spoiled medication ## What If Your Application Is Denied? If your application for the Sandoz One Source program is denied, you have several options: 1. **Request a Review:** Contact Sandoz One Source to understand the reason for denial and discuss whether additional information could support your eligibility 2. **Explore Alternatives:** Ask your healthcare provider about the original Lucentis (ranibizumab) or other treatment options 3. **Contact Patient Advocacy:** Organizations specializing in eye disease may offer additional resources or assistance programs 4. **Discuss with Your Provider:** Your healthcare provider may have information about other patient assistance programs or treatment options ## Biosimilar Alternatives If Cimerli is not available or you are not eligible for this program, your healthcare provider may discuss **Lucentis (ranibizumab)**, the original biologic medication. Lucentis may have its own patient assistance programs available. ## Important Information **Reauthorization:** Contact Sandoz One Source if your income or health insurance coverage changes, as this may affect your eligibility status. **Privacy:** Your personal health information is protected and used only for program enrollment and administration purposes. ## Contact Information **Sandoz One Source Patient Assistance Program** - **Phone:** 1-844-726-3691 - **Fax:** 1-844-726-3695 - **Hours:** Monday–Friday, 8 AM–8 PM ET - **Mailing Address:** P.O. Box 220188, Charlotte, NC 28222 ## Disclaimer This guide provides general information about the Sandoz One Source Patient Assistance Program for Cimerli. Program details, eligibility requirements, and benefits are subject to change. For the most current and accurate information, please contact Sandoz One Source directly or visit the official program website. This information is not a guarantee of eligibility or enrollment. Always consult with your healthcare provider regarding your treatment options and eligibility for assistance programs.

Program information last verified: March 30, 2026